TWIST1 and neuroblastoma: Using an in vivo model for transcriptomic analyses, we then unveiled the impact of CRISPR/Cas9-mediated TWIST1 silencing on NB tumor growth, metastatic colonization, and the reorganization of the tumor microenvironment (TME).